Global Hyaluronic Acid Products Market - Forecast to 2019: Allergan, Anika and Merz dominating
DUBLIN, May 19, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/d98v85/hyaluronic_acid) has announced the addition of the "Global Hyaluronic Acid Products Market - Forecast to 2019: Allergan, Anika and Merz dominating" report to their offering.
Hyaluronic acid (HA) is a unique non-sulfated glycosaminoglycan, distributed throughout the body in connective tissues, epithelial and neural tissues. Hyaluronic acid contributes significantly to cell proliferation and migration and is observed to be an integral component of the extracellular matrix. Hyaluronic acid has wide number of applications such as orthopedic surgery, rheumatology, ophthalmology, otolaryngology, dermatology and plastic surgery, wound healing and drug delivery.
Hyaluronic acid products are segmented on the basis of treatment regimen into single-injection, three-injection cycle and five-injection cycle products. In addition, HA injectable can be utilized in a range of applications such as osteoarthritis, dermal fillers, ophthalmic surgery and vesicoureteral reflux (VUX).
The major factors driving this market are increasing geriatric population globally, high awareness about anti-aging procedures, patient's preference for the treatment with minimum side-effects and rising demand for minimally invasive surgical procedures.
In products segment, five-injection cycle products is the largest market segment and single-injection market segment is growing with highest CAGR during forecast period from 2013 to 2019. Hyaluronic acid products market is observing a global shift in usage of five-injection cycle to single-injection cycle treatment as there has been a considerable change in preference of patients towards short duration treatment.
This shift in preference is mainly related to convenience of patients as they try to avoid side-effects such as redness, inflammation and itching experienced after every treatment and five-injection cycle is a prolonged treatment compared to single-injection.
Dermal fillers is the largest market closely followed by osteoarthritis market and vesicoureteral reflux (VUR) applications market. VUR application market for hyaluronic acid products is growing at a highest CAGR during the forecast period from 2013 to 2019. The segment is mainly driven by aging population, high demand for minimally invasive surgical treatments and high awareness about beauty enhancements.
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Executive Summary
Chapter 3 Market Overview
Chapter 4 Global Hyaluronic Acid Products Market, by Products
Chapter 5 Global Hyaluronic Acid Products Market, by Applications
Chapter 6 Global Hyaluronic Acid Products Market, by Geography
Chapter 7 Recommendations
Chapter 8 Company Profiles
- Alcon, Inc.
- Allergan, Inc.
- Anika Therapeutics, Inc.
- F. Hoffmann-La Roche Ltd.
- Ferring Pharmaceuticals, Inc.
- Fidia Farmaceutici SpA
- GALDERMA S.A.
- Hyaltech Ltd.
- LifeCore Biomedical LLC,
- Meiji Seika Pharma Co., Ltd.
- Merz Aesthetics, Inc.
- Salix Pharmaceuticals, Inc.
- Seikagaku Corporation
- Shanghai Jingfeng Pharmaceutical Co., Ltd.
- Smith & Nephew plc
- TRB CHEMEDICA INTERNATIONAL SA
- Zimmer Holdings, Inc.
For more information visit http://www.researchandmarkets.com/research/d98v85/hyaluronic_acid
Media Contact: Laura Wood, +353-1-481-1716, email@example.com
SOURCE Research and Markets